SCHEMBL5559017

SCHEMBL5559017

CC(C)(C)OC(=O)N(c1ccccc1)C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
RAB9A P51151 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
POLQ O75417 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
BRD4 O60885 1/20 0.37
TDP1 Q9NUW8 2/20 0.37
ATM Q13315 1/20 0.37
AAK1 Q2M2I8 1/20 0.37
PAX8 Q06710 1/20 0.36
GSK3B P49841 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28024917 0.83 MT-CO2 (0.32) LMNAPOLBPAX8
SCHEMBL18751773 0.80 NPSR1 (0.37) MEN1KMT2ANPSR1RAB9ACYP3A4
SCHEMBL27221203 0.79 KMT2A (0.39) MEN1KMT2ANPSR1RAB9ACYP3A4
SCHEMBL3621683 0.79 KMT2A (0.39) MEN1KMT2ANPSR1RAB9ACYP3A4
SCHEMBL18751642 0.79 MEN1 (0.36) MEN1KMT2ANPSR1RAB9ACYP3A4
SCHEMBL2460578 0.79 KMT2A (0.39) MEN1KMT2ANPSR1RAB9ACYP3A4
SCHEMBL27536175 0.79 MEN1 (0.41) MEN1KMT2ANPSR1RAB9ACYP3A4
SCHEMBL9900418 0.78 LOXL2 (0.40) CYP3A4CYP2C9SMN1; SMN2L3MBTL1BRD4
SCHEMBL9899757 0.78 PDK1 (0.42) BRD4GSK3B
SCHEMBL8736767 0.78 MEN1 (0.43) MEN1KMT2ANPSR1RAB9ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101646652-A Quinoline derivatives and pharmaceutical compositions comprising them for selectin inhibition WYETH CORP US 2010-02-10 CN disclosed
EP-1620391-A4 CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL MYERS SQUIBB CO (US) 2007-10-31 EP disclosed
EP-1620391-A2 CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Company (US) 2006-02-01 EP disclosed
WO-2004098516-A2 CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2004-11-18 WO disclosed